|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.70 USD | +5.31% |
|
+16.30% | -57.38% |
| 12-01 | Novocure Limited Announces CEO Changes | CI |
| 12-01 | Novocure appoints company president Frank Leonard as chief executive officer | RE |
| Capitalization | 1.42B 1.22B 1.15B 1.07B 1.97B 128B 2.14B 13.29B 5.17B 60.57B 5.34B 5.22B 223B | P/E ratio 2025 * |
-9.18x | P/E ratio 2026 * | -8.56x |
|---|---|---|---|---|---|
| Enterprise value | 1.42B 1.22B 1.15B 1.07B 1.97B 128B 2.14B 13.29B 5.17B 60.57B 5.34B 5.22B 223B | EV / Sales 2025 * |
2.18x | EV / Sales 2026 * | 2.07x |
| Free-Float |
90.74% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: NovoCure Limited
More recommendations
More press releases
More news
| 1 day | +5.31% | ||
| 1 week | +16.30% | ||
| Current month | -0.86% | ||
| 1 month | +16.30% | ||
| 3 months | +0.32% | ||
| 6 months | -24.85% | ||
| Current year | -57.38% |
| 1 week | 11.36 |  | 12.83 |
| 1 month | 10.79 | | 12.89 |
| Current year | 10.7 | | 31.17 |
| 1 year | 10.7 | | 34.13 |
| 3 years | 10.7 | | 120.03 |
| 5 years | 10.7 | | 232.76 |
| 10 years | 5.95 | | 232.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Leonard
CEO | Chief Executive Officer | 45 | 30/11/2025 |
| Director of Finance/CFO | 51 | 31/12/2024 | |
Nicolas Leupin
CTO | Chief Tech/Sci/R&D Officer | 51 | 03/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Asaf Danziger
BRD | Director/Board Member | 58 | 31/12/2011 |
Bill Doyle
CHM | Chairman | 62 | 31/12/2008 |
Kin Yip Leung
BRD | Director/Board Member | 64 | 04/08/2011 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.19% | 26 M€ | +11.25% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +5.31% | +16.30% | -55.67% | -83.13% | 1.35B | |
| -0.01% | +0.01% | +0.01% | +45.52% | 12.57B | |
| -2.61% | -0.20% | +19.21% | +32.81% | 11.55B | |
| -1.58% | -2.51% | -18.23% | +0.09% | 7.57B | |
| -1.39% | -3.21% | +17.88% | -15.11% | 6.01B | |
| +0.23% | +2.17% | +16.90% | +20.32% | 5.2B | |
| -0.61% | -0.56% | +6.52% | -2.12% | 5.06B | |
| -1.53% | -1.75% | -7.47% | +72.46% | 4.81B | |
| +0.05% | -.--% | +49.78% | +16.90% | 4.7B | |
| -0.68% | -4.64% | +50.25% | -13.01% | 1.99B | |
| Average | -0.29% | +0.81% | +7.92% | +7.47% | 6.08B | |
| Weighted average by Cap. | -0.89% | -0.29% | +8.80% | +20.49% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 651M 560M 525M 489M 901M 58.51B 979M 6.09B 2.37B 27.73B 2.44B 2.39B 102B | 688M 591M 554M 517M 951M 61.8B 1.03B 6.43B 2.5B 29.29B 2.58B 2.53B 108B |
| Net income | -155M -133M -125M -117M -215M -13.94B -233M -1.45B -564M -6.61B -582M -570M -24.34B | -172M -148M -139M -129M -238M -15.46B -259M -1.61B -625M -7.33B -646M -632M -27B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
1,488
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/12/25 | 12.70 $ | +5.31% | 2,251,102 |
| 08/12/25 | 12.06 $ | -0.41% | 1,403,958 |
| 05/12/25 | 12.11 $ | +2.98% | 2,254,906 |
| 04/12/25 | 11.76 $ | -0.42% | 1,787,474 |
| 03/12/25 | 11.81 $ | +8.15% | 2,330,116 |
Delayed Quote Nasdaq, December 09, 2025 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
12.06USD
Average target price
24.93USD
Spread / Average Target
+106.70%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NVCR Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition